Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
Background. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs ha...
Main Authors: | Amir Taherkhani, Parita Khodadadi, Lida Samie, Zahra Azadian, Zeynab Bayat |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | International Journal of Analytical Chemistry |
Online Access: | http://dx.doi.org/10.1155/2023/8899240 |
Similar Items
-
Natural Anthraquinones as Promising MAPK3 Inhibitors for Complementary Cancer Therapy
by: Samaneh Vaziri-Amjad, et al.
Published: (2023-01-01) -
Computational Studies Of Natural Flavonoids Towards
The Discovery Of A Potential Xanthine Oxidase Inhibitor.
by: Mohammad Alnajjar, Belal Omar
Published: (2008) -
MAPK-specific tyrosine phosphatases: new targets for drug discovery?
by: Barr, A, et al.
Published: (2006) -
MAPK-specific tyrosine phosphatases: new targets for drug discovery?
by: Barr, A, et al.
Published: (2006) -
Computer-Aided Drug Design Boosts RAS Inhibitor Discovery
by: Ge Wang, et al.
Published: (2022-09-01)